Evotec SE
EVOTFOTCHealthcare● Active
$6.69
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$8.58
52W Low$4.725
Evotec SE (EVOTF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EVOTF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.79B | $0.80B | $0.78B | $0.75B | $0.62B |
| Cost of Revenue | $0.72B | $0.68B | $0.61B | $0.58B | $0.47B |
| Gross Profit | $0.07B | $0.11B | $0.18B | $0.17B | $0.15B |
| Gross Margin %(computed) | 8.27% | 14.41% | 22.40% | 23.16% | 24.52% |
| Operating Expenses | |||||
| R&D Expenses | $0.08B | $0.05B | $0.07B | $0.08B | $0.07B |
| G&A Expenses | $0.00B | $0.17B | $0.15B | $0.14B | $0.10B |
| Total Operating Expenses | $0.21B | $0.26B | $0.22B | $0.15B | $0.11B |
| Operating Income | ($0.14B) | ($0.14B) | ($0.05B) | $0.02B | $0.04B |
| Operating Margin %(computed) | -17.87% | -17.88% | -6.08% | 2.77% | 6.63% |
| Interest Income | $0.00B | $0.00B | $0.01B | $0.01B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | ($0.13B) | ($0.19B) | ($0.08B) | ($0.15B) | $0.24B |
| Income Tax Expense | ($0.02B) | $0.00B | $0.00B | $0.02B | $0.02B |
| Net Income | ($0.10B) | ($0.20B) | ($0.08B) | ($0.18B) | $0.22B |
| Net Margin %(computed) | -13.13% | -24.60% | -10.74% | -23.38% | 34.87% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.58 | $-1.11 | $-0.47 | $-0.99 | $1.30 |
| Wtd Avg Shares | 0.18B | 0.18B | 0.18B | 0.18B | 0.17B |
| EBITDA | ($0.04B) | ($0.08B) | $0.02B | ($0.06B) | $0.31B |
| EBITDA Margin %(computed) | -5.25% | -10.12% | 3.09% | -7.87% | 50.78% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B
Explore more Evotec SE data
About Evotec SE (EVOTF) Income Statement
Evotec SE (EVOTF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EVOTF reported revenue of $0.79B, gross profit of $0.07B (gross margin 8.27%), and net income of ($0.10B) — a net profit margin of -13.13%.
Frequently asked questions
EVOTF · 4 questionsEvotec SE (EVOTF) reported revenue of $0.79B for 2025, down 1.1% year-over-year.
EVOTF revenueEVOTF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08